Found: 172
Select item for more details and to access through your institution.
Serum levels of cytoplasmic melanoma-associated antigen at diagnosis may predict clinical relapse in neuroblastoma patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 10, p. 1485, doi. 10.1007/s00262-011-1052-0
- By:
- Publication type:
- Article
Deficiency of activated STAT1 in head and neck cancer cells mediates TAP1-dependent escape from cytotoxic T lymphocytes.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 4, p. 525, doi. 10.1007/s00262-010-0961-7
- By:
- Publication type:
- Article
Response to the letter to the editors by Ottaiano et al.: “Cetuximab-dependent ADCC in cancer: dream or reality?”.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 4, p. 529, doi. 10.1007/s00262-009-0769-5
- By:
- Publication type:
- Article
Relationship between HLA class I antigen processing machinery component expression and the clinicopathologic characteristics of bladder carcinomas.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 3, p. 465, doi. 10.1007/s00262-009-0765-9
- By:
- Publication type:
- Article
Role of polymorphic Fc gamma receptor IIIa and EGFR expression level in cetuximab mediated, NK cell dependent in vitro cytotoxicity of head and neck squamous cell carcinoma cells.
- Published in:
- 2009
- By:
- Publication type:
- Correction notice
Role of polymorphic Fc gamma receptor IIIa and EGFR expression level in cetuximab mediated, NK cell dependent in vitro cytotoxicity of head and neck squamous cell carcinoma cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 11, p. 1855, doi. 10.1007/s00262-009-0697-4
- By:
- Publication type:
- Article
Breast cancer cells expressing stem cell markers CD44<sup>+</sup> CD24<sup>lo</sup> are eliminated by Numb-1 peptide-activated T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 8, p. 1185, doi. 10.1007/s00262-008-0623-1
- By:
- Publication type:
- Article
Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by Natural Killer cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 6, p. 855, doi. 10.1007/s00262-008-0601-7
- By:
- Publication type:
- Article
Interferon regulatory factor 8 mediates tumor-induced inhibition of antigen processing and presentation by dendritic cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 4, p. 567, doi. 10.1007/s00262-008-0579-1
- By:
- Publication type:
- Article
Chordoma and chondrosarcoma gene profile: implications for immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 3, p. 339, doi. 10.1007/s00262-008-0557-7
- By:
- Publication type:
- Article
Targeting 11q23 positive acute leukemia cells with high molecular weight-melanoma associated antigen-specific monoclonal antibodies.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 3, p. 415, doi. 10.1007/s00262-008-0567-5
- By:
- Publication type:
- Article
Total HLA class I loss in a sarcomatoid renal carcinoma cell line caused by the coexistence of distinct mutations in the two encoding β<sub>2</sub>-microglobulin genes.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 3, p. 395, doi. 10.1007/s00262-008-0565-7
- By:
- Publication type:
- Article
Regulation of antigen presentation machinery in human dendritic cells by recombinant adenovirus.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 1, p. 121, doi. 10.1007/s00262-008-0533-2
- By:
- Publication type:
- Article
Peptides mimicking GD2 ganglioside elicit cellular, humoral and tumor-protective immune responses in mice.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 7, p. 1079, doi. 10.1007/s00262-007-0439-4
- By:
- Publication type:
- Article
Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 2, p. 197, doi. 10.1007/s00262-007-0362-8
- By:
- Publication type:
- Article
NY-BR-1 protein expression in breast carcinoma: a mammary gland differentiation antigen as target for cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 11, p. 1723, doi. 10.1007/s00262-007-0316-1
- By:
- Publication type:
- Article
Immune selective pressure and HLA class I antigen defects in malignant lesions.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 2, p. 227, doi. 10.1007/s00262-006-0183-1
- By:
- Publication type:
- Article
T-Cell activation by t(9;22) acute lymphoblastic leukemia-derived dendritic-like cells is associated with increased tapasin expression.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 2, p. 160, doi. 10.1007/s00262-005-0012-y
- By:
- Publication type:
- Article
α<sub>v</sub>β<sub>3</sub> expression on blood vessels and melanoma cells in primary lesions; differential association with tumor progression and clinical prognosis.
- Published in:
- Cancer Immunology, Immunotherapy, 2000, v. 49, n. 6, p. 314, doi. 10.1007/s002620000124
- By:
- Publication type:
- Article
Disulfiram Acts as a Potent Radio-Chemo Sensitizer in Head and Neck Squamous Cell Carcinoma Cell Lines and Transplanted Xenografts.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 3, p. 517, doi. 10.3390/cells10030517
- By:
- Publication type:
- Article
Association of immunoescape mechanisms with Epstein-Barr virus infection in nasopharyngeal carcinoma.
- Published in:
- International Journal of Cancer, 2007, v. 120, n. 11, p. 2401, doi. 10.1002/ijc.22334
- By:
- Publication type:
- Article
Cytoplasmic melanoma-associated antigen (CYT-MAA) serum level in patients with melanoma: A potential marker of response to immunotherapy?
- Published in:
- International Journal of Cancer, 2006, v. 119, n. 1, p. 157, doi. 10.1002/ijc.21820
- By:
- Publication type:
- Article
Molecular mechanisms of HLA class I antigen abnormalities following viral infection and transformation.
- Published in:
- International Journal of Cancer, 2006, v. 118, n. 1, p. 129, doi. 10.1002/ijc.21312
- By:
- Publication type:
- Article
Suppression of human melanoma tumor growth in SCID mice by a human high molecular weight-melanoma associated antigen (HMW-MAA) specific monoclonal antibody.
- Published in:
- International Journal of Cancer, 2005, v. 114, n. 3, p. 426, doi. 10.1002/ijc.20769
- By:
- Publication type:
- Article
MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma.
- Published in:
- International Journal of Cancer, 2004, v. 109, n. 2, p. 265, doi. 10.1002/ijc.11681
- By:
- Publication type:
- Article
TAP1 down-regulation in primary melanoma lesions: An independent marker of poor prognosis.
- Published in:
- International Journal of Cancer, 2001, v. 95, n. 1, p. 23, doi. 10.1002/1097-0215(20010120)95:1<23::AID-IJC1004>3.0.CO;2-4
- By:
- Publication type:
- Article
Differential clinical significance of α.
- Published in:
- International Journal of Cancer, 2000, v. 89, n. 2, p. 153, doi. 10.1002/(SICI)1097-0215(20000320)89:2<153::AID-IJC9>3.0.CO;2-1
- By:
- Publication type:
- Article
Natural variation of the expression of HLA and endogenous antigen modulates CTL recognition in an In vitro melanoma model.
- Published in:
- International Journal of Cancer, 1999, v. 80, n. 5, p. 781, doi. 10.1002/(SICI)1097-0215(19990301)80:5<781::AID-IJC24>3.0.CO;2-A
- By:
- Publication type:
- Article
Improved tumor targeting of rhenium-186-labeled anti-human high-m.w. melanoma-associated antigen monoclonal antibody 763.74 following purification with anti-idiotypic monoclonal antibody MK2-23.
- Published in:
- International Journal of Cancer, 1998, v. 78, n. 4, p. 486, doi. 10.1002/(SICI)1097-0215(19981109)78:4<486::AID-IJC15>3.0.CO;2-4
- By:
- Publication type:
- Article
Turning anecdotal irradiation-induced anticancer immune responses into reproducible in situ cancer vaccines via disulfiram/copper-mediated enhanced immunogenic cell death of breast cancer cells.
- Published in:
- Cell Death & Disease, 2024, v. 15, n. 4, p. 1, doi. 10.1038/s41419-024-06644-3
- By:
- Publication type:
- Article
Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?
- Published in:
- Cellular & Molecular Life Sciences, 2011, v. 68, n. 3, p. 417, doi. 10.1007/s00018-010-0583-4
- By:
- Publication type:
- Article
Perspectives in melanoma: meeting report from the Melanoma Bridge (November 29th-1 December 1st, 2018, Naples, Italy).
- Published in:
- 2019
- By:
- Publication type:
- journal article
Perspectives in melanoma: Meeting report from the Melanoma Bridge (30 November-2 December, 2017, Naples, Italy).
- Published in:
- 2018
- By:
- Publication type:
- research
Immunotherapy of Melanoma Targeting Human High Molecular Weight Melanoma-Associated Antigen Potential Role of Nonimmunological Mechanisms.
- Published in:
- Annals of the New York Academy of Sciences, 2004, v. 1028, n. 1, p. 340, doi. 10.1196/annals.1322.040
- By:
- Publication type:
- Article
Immunogenicity of Human Neuroblastoma.
- Published in:
- Annals of the New York Academy of Sciences, 2004, v. 1028, n. 1, p. 69, doi. 10.1196/annals.1322.008
- By:
- Publication type:
- Article
Melanoma chondroitin sulfate proteoglycan enhances FAK and ERK activation by distinct mechanisms.
- Published in:
- Journal of Cell Biology, 2004, v. 165, n. 6, p. 881, doi. 10.1083/jcb.200403174
- By:
- Publication type:
- Article
High TIL, HLA, and Immune Checkpoint Expression in Conventional High-Grade and Dedifferentiated Chondrosarcoma and Poor Clinical Course of the Disease.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.598001
- By:
- Publication type:
- Article
Enrichment of CD56<sup>dim</sup>KIR+CD57+ highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patients.
- Published in:
- Nature Communications, 2014, v. 5, n. 12, p. 5639, doi. 10.1038/ncomms6639
- By:
- Publication type:
- Article
Constitutive and TNFα-inducible expression of chondroitin sulfate proteoglycan 4 in glioblastoma and neurospheres: Implications for CAR-T cell therapy.
- Published in:
- Science Translational Medicine, 2018, v. 10, n. 430, p. 1, doi. 10.1126/scitranslmed.aao2731
- By:
- Publication type:
- Article
Multiparametric plasma EV profiling facilitates diagnosis of pancreatic malignancy.
- Published in:
- Science Translational Medicine, 2017, v. 9, n. 391, p. 1, doi. 10.1126/scitranslmed.aal3226
- By:
- Publication type:
- Article
Survival of the fittest or best adapted: HLA-dependent tumor development.
- Published in:
- Journal of Nucleic Acids Investigation, 2010, v. 1, n. 1-9, p. 41, doi. 10.4081/jnai.2010.1654
- By:
- Publication type:
- Article
Melanoma Targeting with a Cocktail of Monoclonal Antibodies to Distinct Determinants of the Human HMW-MAA.
- Published in:
- Journal of Nuclear Medicine, 1989, v. 30, n. 3, p. 390
- By:
- Publication type:
- Article
VT68.2: An Antibody to Chondroitin Sulfate Proteoglycan 4 (CSPG4) Displays Reactivity against a Tumor-Associated Carbohydrate Antigen.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 3, p. 2506, doi. 10.3390/ijms24032506
- By:
- Publication type:
- Article
Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GIST.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 18, p. N.PAG, doi. 10.3390/ijms231810368
- By:
- Publication type:
- Article
<sup>212</sup>Pb-Labeled Antibody 225.28 Targeted to Chondroitin Sulfate Proteoglycan 4 for Triple-Negative Breast Cancer Therapy in Mouse Models.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 4, p. 925, doi. 10.3390/ijms19040925
- By:
- Publication type:
- Article
WHO grade associated downregulation of MHC class I antigen-processing machinery components in human astrocytomas: does it reflect a potential immune escape mechanism?
- Published in:
- Acta Neuropathologica, 2007, v. 114, n. 2, p. 111, doi. 10.1007/s00401-007-0231-8
- By:
- Publication type:
- Article
CSPG4 Protein as a New Target for the Antibody-Based Immunotherapy of Triple-Negative Breast Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 19, p. 1496, doi. 10.1093/jnci/djq343
- By:
- Publication type:
- Article
Polyclonality of BRAF Mutations in Acquired Melanocytic Nevi.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2009, v. 101, n. 20, p. 1423, doi. 10.1093/jnci/djp309
- By:
- Publication type:
- Article
Iron and Ferritin Modulate MHC Class I Expression and NK Cells Recognition.
- Published in:
- Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.00224
- By:
- Publication type:
- Article